zidovudine has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alonso, D; Donia, MS; Franzblau, SG; Garcia-Palomero, E; Hamann, MT; Khan, SI; Martinez, A; Medina, M; Peng, J; Rao, KV; Tekwani, BL; Wahyuono, S; Willett, KL | 1 |
| Chitolina Schetinger, MR; Dorneles Rodrigues, OE; Ineu, RP; Oliveira, VA; Pereira, ME; Saraiva, RA; Souza, D; Teixeira Rocha, JB; Thomé, GR | 1 |
2 other study(ies) available for zidovudine and Alzheimer Disease
| Article | Year |
|---|---|
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases.
Topics: Alzheimer Disease; Animals; Female; Glycogen Synthase Kinase 3; HIV-1; Humans; Indole Alkaloids; Indonesia; Inhibitory Concentration 50; Leishmania donovani; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oryzias; Plasmodium falciparum; Porifera; Structure-Activity Relationship | 2006 |
Selenothymidine protects against biochemical and behavioral alterations induced by ICV-STZ model of dementia in mice.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Behavior, Animal; Binding Sites; Brain; Catalase; Catalytic Domain; Disease Models, Animal; Infusions, Intraventricular; Maze Learning; Memory; Mice; Molecular Docking Simulation; Neuroprotective Agents; Organoselenium Compounds; Oxidative Stress; Streptozocin; Zidovudine | 2018 |